Biotech · Private company
Peregrine Ophthalmic
Track this companyFree. Adds Peregrine Ophthalmic to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Latanoprost ophthalmic solutionPhase 2 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- POLAT-001Phase 2 · GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- POLAT-001Phase 1 · Lower Eyelid SteatoblepharonClinicalTrials.gov · fetched Nov 12, 2026
- Observation onlyGlaucomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid SteatoblepharonPHASE1 · COMPLETED · started Apr 28, 2023ClinicalTrials.gov NCT05935527 · fetched Nov 12, 2026
- Open Label Extension of LipoLat-CS202COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02599688 · fetched Nov 12, 2026
- POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle GlaucomaPHASE2 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02466399 · fetched Nov 12, 2026